UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia

被引：5

作者：

Iurlo, Alessandra ^{[1
]}

Bucelli, Cristina ^{[1
]}

Cattaneo, Daniele ^{[1
]}

Levati, Giorgia Virginia ^{[1
]}

Viani, Benedetta ^{[1
]}

Tavazzi, Dario ^{[2
,3
]}

Consonni, Dario ^{[4
]}

Baldini, Luca ^{[1
]}

Cappellini, Maria Domenica ^{[2
,3
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Div, Milan, Italy

[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 11期

关键词：

RECOMMENDATIONS; CHEMOTHERAPY; MANAGEMENT; NILOTINIB;

D O I：

10.1002/ajh.25596

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E283 / E285

页数：3

共 10 条

[1] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].

Baccarani, Michele ;

Deininger, Michael W. ;

Rosti, Gianantonio ;

Hochhaus, Andreas ;

Soverini, Simona ;

Apperley, Jane F. ;

Cervantes, Francisco ;

Clark, Richard E. ;

Cortes, Jorge E. ;

Guilhot, Francois ;

Hjorth-Hansen, Henrik ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Mahon, Francois-Xavier ;

Martinelli, Giovanni ;

Mayer, Jiri ;

Mueller, Martin C. ;

Niederwieser, Dietger ;

Pane, Fabrizio ;

Radich, Jerald P. ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Schiffer, Charles ;

Silver, Richard ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Goldman, John M. ;

Hehlmann, Ruediger .

BLOOD, 2013, 122 (06) :872-884

[2] The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML) [J].

Bahk, Jeeyune ;

Claudiani, Simone ;

Szydlo, Richard M. ;

Toma, Sarmad ;

Abdillah, Faisal ;

Hing, Sandra ;

Deplano, Simona ;

Milojkovic, Dragana ;

Apperley, Jane F. ;

Foroni, Letizia .

BLOOD, 2015, 126 (23)

[3] Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening [J].

Berrueco, R. ;

Alonso-Saladrigues, A. ;

Martorell-Sampol, L. ;

Catala-Temprano, A. ;

Ruiz-Llobet, A. ;

Toll, T. ;

Torrebadell, M. ;

Naudo, M. ;

Camos, M. ;

Rives, S. .

PEDIATRIC BLOOD & CANCER, 2015, 62 (07) :1195-1201

[4] Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation [J].

Ehmer, Ursula ;

Kalthoff, Sandra ;

Fakundiny, Bastian ;

Pabst, Brigitte ;

Freiberg, Nicole ;

Naumann, Ronald ;

Manns, Michael P. ;

Strassburg, Christian P. .

HEPATOLOGY, 2012, 55 (06) :1912-1921

[5]

Esquirol A, 2010, HAEMATOLOGICA, V95, pS12

[6] Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature [J].

Ha, Vincent H. ;

Jupp, Jennifer ;

Tsang, Roger Y. .

PHARMACOTHERAPY, 2017, 37 (08) :956-972

[7] Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients [J].

Nomura, Akitaka ;

Maruo, Yoshihiro ;

Taga, Takashi ;

Takeuchi, Yoshihiro .

PEDIATRIC RESEARCH, 2016, 80 (02) :252-257

[8] Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia [J].

Shibata, Takashi ;

Minami, Yosuke ;

Mitsuma, Ayako ;

Morita, Sachi ;

Inada-Inoue, Megumi ;

Oguri, Tomoyo ;

Shimokata, Tomoya ;

Sugishita, Mihoko ;

Naoe, Tomoki ;

Ando, Yuichi .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) :391-396

[9] UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia [J].

Singer, J. B. ;

Shou, Y. ;

Giles, F. ;

Kantarjian, H. M. ;

Hsu, Y. ;

Robeva, A. S. ;

Rae, P. ;

Weitzman, A. ;

Meyer, J. M. ;

Dugan, M. ;

Ottmann, O. G. .

LEUKEMIA, 2007, 21 (11) :2311-2315

[10] European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia [J].

Steegmann, J. L. ;

Baccarani, M. ;

Breccia, M. ;

Casado, L. F. ;

Garcia-Gutierrez, V. ;

Hochhaus, A. ;

Kim, D-W ;

Kim, T. D. ;

Khoury, H. J. ;

Le Coutre, P. ;

Mayer, J. ;

Milojkovic, D. ;

Porkka, K. ;

Rea, D. ;

Rosti, G. ;

Saussele, S. ;

Hehlmann, R. ;

Clark, R. E. .

LEUKEMIA, 2016, 30 (08) :1648-1671

← 1 →